Skip to content

FDA Boosts Testing By Authorizing At-Home Collection

April 21, 2020

Key points: 

-The FDA announced today they have “authorized the first diagnostic test with a home collection option for COVID-19,” increasing our country’s testing capacities.

-This means some patients will soon be able to take a COVID-19 test at home, send the sample to a lab and get the results.

– At-home collection of samples is a critical breakthrough to mitigate the risks, especially for vulnerable populations, associated with leaving the house and going to a testing facility.


Together with LabCorp, the federal government authorized at-home test kits for patients as we work to stop COVID-19. While this does not authorize all at-home testing kits, it is a major step forward to increase the number of tests our country will be able to complete – a big step forward in locking down the virus.

“We worked with LabCorp to ensure the data demonstrated from at-home patient sample collection is as safe and accurate as sample collection at a doctor’s office, hospital or other testing site,” FDA Commissioner Stephen Hahn, M.D. said. “With this action, there is now a convenient and reliable option for patient sample collection from the comfort and safety of their home.”

LabCorp said they intend to make these at-home testing kits available in most states in the coming weeks. Patients can receive a test with a doctor’s order. The FDA stressed that this new authorization is for the LabCorp home self-collection kit only and does not apply to any other at-home testing kits.

Want to read more on the fight against Coronavirus? Read our Coronavirus Bulletin here which contains our extensive FAQ about recent federal actions.

Was this message forwarded to you? CLICK HERE to subscribe to our emails.